Previous 10 | Next 10 |
Zynex ([[ZYXI]] +4.4%) says it has received board approval to repurchase $10M of shares through expiry of Sep. 8, 2021."We believe that the current market value of our shares does not accurately reflect the underlying value of the Company and the buyback program represents an attractive oppor...
Zynex Announces Share Buyback Program PR Newswire ENGLEWOOD, Colo. , March 8, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manageme...
The following slide deck was published by Zynex, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Zynex, Inc. 2020 Q4 - Results - Earnings Call Presentation
Gainers: Xtant Medical (XTNT) +189%.Intrusion (INTZ) +33%.Armstrong Flooring (AFI) +28%.Just Energy Group (JE) +28%.AMC Networks (AMCX) +26%.Applied UV (AUVI) +24%.Fisker (FSR) +21%.Ocugen (OCGN) +20%.Select Medical (SEM) +19%.Rubius Therapeutics (RUBY) +19%.Losers: Tricid...
Shares of Zynex (NASDAQ: ZYXI) were crashing 17.8% lower as of 11:21 a.m. EST on Friday. The steep drop came after the medical technology company announced its fourth-quarter results following the market close on Thursday. It wasn't that Zynex's Q4 results were bad. The company ...
Gainers: Xtant Medical (XTNT) +54%, Sensus Healthcare (SRTS) +34%, Rubius Therapeutics (RUBY) +23%, Select Medical (SEM) +18%, Dynavax Technologies (DVAX) +18%.Losers: Tricida (TCDA) -32%, Recro Pharma (REPH) -27%, Zynex (ZYXI) -17%,...
Image source: The Motley Fool. Zynex, Inc (NASDAQ: ZYXI) Q4 2020 Earnings Call Feb 25, 2021 , 4:15 p.m. ET Operator Continue reading For further details see: Zynex, Inc (ZYXI) Q4 2020 Earnings Call Transcript
Fate Therapeutics (FATE) initiated with a Buy at BofA Securities. PT set to $115, implies a 33% increase from last price.Wedbush analyst David Nierengarten downgraded FATE to Neutral from Outperform as it sees “higher downside risk”and less reward as clinical programs advance an...
Zynex, Inc. (ZYXI) Q4 2020 Results Earnings Conference Call February 25, 2021, 04:15 PM ET Company Participants Thomas Sandgaard - Founder, Chairman, and Chief Executive Officer Dan Moorhead - Chief Financial Officer Conference Call Participants Yi Chen - H.C. Wainwright & Co. Jeffrey Coh...
Zynex Announces 2020 Fourth Quarter and Full Year Earnings PR Newswire ENGLEWOOD, Colo. , Feb. 25, 2021 /PRNewswire/ -- 2020 Full Year Revenue increased 76% year over year to $80.1 million Orders increased 96% Net...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...